Brain

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:21 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

World’s biggest deal for Humanoid Robots inked

Source Node:
Time Stamp: August 4, 2022 12:13 PM - Modified On: August 4, 2022 - Published By:
Source Cluster:
Republished By Plato

Robotics innovator Beyond Imagination, Inc. has entered into an agreement with SELF Labs, Inc. to provide at least 1,000 humanoid robots for use in agricultural “grow boxes''. This is believed to be the largest deal of its kind. SELF and Beyond are announcing a partnership to develop automated off-the-grid grow boxes. Each box will be equipped with solar panels, windmills, atmospheric water generators, 5G, and an advanced version of Beyond Imagination’s Beomni™ robot with its Omni-Purpose AI Brain. By aligning the visions of Milan Cheeks of SELF and Dr. Harry

How Technology Aids Your Brain When Solving Puzzles

Source Node:
Time Stamp: June 26, 2022 12:06 PM - Modified On: June 26, 2022 - Published By:
Source Cluster:
Republished By Plato

In addition to being enjoyable, solving puzzles requires a serious mental effort. Both families and individuals can enjoy solving puzzles. It doesn't matter if your preferred problem is a 1,000-piece jigsaw, the Sunday crossword puzzle from the New York Times, a wooden brain teaser, or a 3D mechanical puzzle; all puzzles have one thing in common: they stimulate your brain. In the digital age, puzzles are still highly popular, although this trend has a very long history. Since the time of the ancient world, puzzles have appeared in a variety